S infant mortality declines, congenital and genetic disorders emerge as important causes of early death and chronic disability, 1 and developing countries need strategies for integrating genetic approaches into health care. 2 Pakistan has a population of over 140 million people, 40 percent of whom are younger than 15 years of age; the literacy rate is low, and the average income is $420 per year. 3 The crude birth rate is 29 per 1000 population, A and the infant mortality rate is 101 per 1000 live births. The health system is hospital-based, and primary care is practically nonexistent. 4 As in most of North Africa, the Middle East, and South India, there is a strong cultural preference for consanguineous marriage and an associated relatively high prevalence of recessively inherited disorders. 5 The hemoglobinopathies are major genetic problems in Pakistan. 2 About 5 percent of the Pakistani population carries b -thalassemia, and 0.5 to 1 percent carry hemoglobin S or hemoglobin E. 6, 7 Married couples consisting of two carriers have a 25 percent chance that any child they have will be affected. The estimated rate of birth of affected infants is 1.3 per 1000 live births, and about 5250 infants with b -thalassemia major are born annually. 2 Although only a minority of these cases are diagnosed, charitable thalassemia centers sustain thousands of affected children with monthly blood transfusions. Such transfusions permit an excellent quality of life during childhood but lead to iron overload and death in adolescence or early adult life. 8 The average annual cost of iron-chelation therapy with deferoxamine -$4,400 per patient, or 10 times the average annual income -is prohibitive. The requirements for treating one annual birth cohort of affected children for one year are 90,000 units of blood plus $22 million worth of deferoxamine -more than 4 percent of the current health-related expenditures of the government. As treated children began to survive longer, costs might reach 40 percent of current expenditures for health care.
Screening to identify carriers, genetic counseling, and prenatal diagnosis can greatly reduce the rate of birth of affected infants and improve the prognosis of affected patients. [9] [10] [11] In Pakistan, first-trimester prenatal diagnosis (by chorionic-villus sampling and polymerase chain reaction [PCR] ) is not objected to on religious grounds and is acceptable and affordable to most families who are at risk. When the fetus is affected, 89 percent of couples choose to terminate the pregnancy. 12, 13 However, the weak health care infrastructure makes it impossible to provide population screening.
In societies in which most couples are unrelated, genes for recessive disorders usually run in families for many generations without manifesting themselves through the birth of an affected child. By contrast, in communities with a cultural preference for consanguineous marriage, as in Pakistan, when a gene for a recessive disorder is present in a kindred, there is likely to be an affected child in at least one branch of the extended family. In turn, the diagnosis of disease in a child serves as a marker of an extended family that is at increased genetic risk. Therefore, in such communities, studies of extended families beginning with the first child with a diagnosis may offer an alternative to population screening for identifying present and future couples at risk for producing affected children. 2 Our study was designed to test this hypothesis, using hemoglobin disorders as a model.
METHODS

Study Setting
We conducted the study at the Armed Forces Institute of Pathology in Rawalpindi (in the northern region of Pakistan), which supports several thalassemia centers that provide care for affected children, testing to identify carriers, counseling, and prenatal diagnosis.
Testing of Extended Families
Fifteen families of children with a hemoglobin disorder, one family of a carrier of b -thalassemia, and eight control families with no history of a hemoglobin disorder were offered testing to identify carriers. Criteria for selection were voluntary participation and the availability of many family members. Genetic counseling was conducted according to internationally accepted guidelines. 14 A meeting was arranged with key members of each family (in affected families, usually the parents of the child with the index case) in order to explain the importance of testing to identify other carriers. When family representatives agreed, a three-generation pedigree was drawn up, and arrangements were made for testing family members at their homes. Results were given to the carriers themselves (or to the parents when a carrier was less than 15 years old). The meaning of carrier status, the importance of knowing whether or not one's partner was a carrier, the availability of prenatal diagnosis, and (for those not yet married) the possibility of taking test results into account when planning marriage, were explained orally.
Antenatal Screening
For comparison with antenatal screening, testing was offered to 350 consecutive women who were attending a local hospital early in their pregnancies. They were informed orally of the relevance of the test and the availability of prenatal diagnosis should they prove to be at risk. When a carrier was identified, her partner was offered immediate testing.
Identification of Carriers
When the child with the index case had sickle cell anemia, screening to identify carriers was performed by cellulose acetate electrophoresis; red-cell indexes were not measured, because of technical limitations. Screening for thalassemia followed a stepwise approach. First, red-cell indexes (hemoglobin, mean cell volume, and mean cell hemoglobin) were measured with an electronic counter. When there was marked microcytosis (mean cell hemoglobin, «25 pg, or mean cell volume, «75 fl), hemoglobin A 2 was measured by cellulose acetate elution 15 ; b -thalassemia trait was diagnosed when the percentage of hemoglobin A 2 was 3.5 percent or higher. 16 The specific thalassemia mutations in all affected children and all carriers were identified by PCR with the use of methods that have been described elsewhere. 17 
Follow-up of Families
The parents of the child with the index case were asked at intervals about engagements, marriages, and births to couples within the family who were at risk of having affected children. It was not possible for investigators to keep track of family members who lived far away, but when affected children were born, they were brought to the center; prenatal diagnosis was performed at the center as well.
RESULTS
Study Families
A total of 16 families with an index case of a hemoglobin disorder were approached, and 10 requested testing to identify carriers. The other six families declined for various reasons, including difficulty in getting everyone together, desire to avoid testing because they were apparently healthy, and concern about possible problems in arranging marriages or about the stigma that would be attached to carrier status. Eight control families with no history of a hemoglobin disorder were approached, and five of these families agreed to undergo testing. The other three families declined because of the difficulty of asking people to give blood with no obvious benefit to them.
A typical pedigree of a family with an index case is shown in Figure 1 . The 15 study families included a total of 1455 living members (Table 1 ). There were 338 married couples, of which 44 percent were consanguineous (second cousins or closer relatives), 49 percent were from the same biradri (tribe or subdivision of a tribe), and 6 percent were completely unrelated. Although there was considerable interfamily variation in the proportion of marriages that were consanguineous, there was no major difference in the mean proportion between the group of index families and the control group.
The test results are summarized in Table 2 . Testing was greatly facilitated when it was supported by an influential family member. It was easiest to undertake testing in rural areas because most people were readily available, whereas in urban areas, men and school-age children were away during the day. Most of those who were not tested live in remote areas; there is no indication that they are at lower risk than the rest of their family.
tories revealed that there were another 19 affected children, 6 of whom were alive and 13 of whom had died (Table 2) . Of 846 living family members, 591 (70 percent) were tested and 183 (31 percent) were found to be carriers. Among the 214 married couples tested, we found 86 carriers, 34 of whom were married to another carrier. Nine of the 17 couples who were at risk were the parents of the child with the index case in their family; 6 more couples consisting of two carriers were identified by the family history (they had already had one or more affected children), and 2 such couples were identified by testing. All couples at risk were informed of the availability of prenatal diagnosis. A total of 97 unmarried carriers were identified and informed of their genetic risk and of the availability of prenatal diagnosis, should their chosen partner also be a carrier.
In Family 8, a carrier had been identified incidentally. Our study showed that a b -thalassemia gene had entered this family three generations previously through a marriage to a completely unrelated person. The gene was present in only one branch of the family, but Figure 2 shows that the members of the youngest generation in this branch have a high chance of entering a marriage that would be at risk for producing affected children. Although six different mutations were found (Table 2 ), in 9 of the 10 families we studied all the carriers had the same mutation.
Control Families
Of 609 living members of the control families, 397 (65 percent) were tested, but no carrier was identified.
Antenatal Screening
All 350 pregnant women who were approached agreed to undergo testing, and 17 of them (5 percent) were found to carry b -thalassemia. All partners of these 17 women were tested, but no couple was identified as at risk.
Use of Information on Risk
It has been possible to conduct four years of regular follow-up through informal visits in 8 of the 10 index families. To date, there have been seven new marriages and engagements, and family members said that test results were taken into account when they were arranged. Four consanguineous couples were known not to be at risk; in three, one partner was a known carrier and the other a known noncarrier; and in one, the man was a known noncarrier, so the woman was not tested. One consanguineous couple who had not taken part in the study came spontaneously for premarital testing and was found not to be at risk.
Two men who were carriers and were marrying more "distant" women (one marrying a second cousin, and one marrying within the biradri) married women who had not been tested. In one case, three previous engagements had been broken, the marriage was arranged with difficulty, and the family did not wish to disclose the problem. In the other case, two engagements had been broken after the man's carrier status was disclosed; it was not mentioned during the third engagement, and the bride was found not to be a carrier after marriage. There have so far been no reports that a marriage was avoided explicitly because both partners were carriers. In these families to date, no couple at risk with two or more healthy children has undertaken a further pregnancy, and seven prenatal diagnoses have been performed for six couples at risk with no, or only one, healthy child. A couple that was prospectively identified as at risk and that had one unaffected child declined prenatal diagnosis for religious reasons and had an affected child.
DISCUSSION
We tested the possibility of deploying modern genetic technology appropriately and cost effectively in a developing country. Our hypothesis was that in communities with a cultural preference for consanguineous marriage, gene variants are trapped within extendedfamily groupings. Hence, an affected child is a marker of a group at high genetic risk, and studies of the extended family may identify many carriers and couples at risk before marriage or reproduction. 2 We tested the hypothesis by offering testing to identify carriers to 16 extended families with a history of a hemoglobin disorder, 8 control families with no such history, and 350 randomly selected pregnant women (for comparison with antenatal screening). About two thirds of the families we approached agreed to undergo testing, and two thirds of their 1455 members were tested.
As would have been expected, 5 percent of the women who were screened early in pregnancy and 31 percent of the members of families with an affected relative were found to be carriers. 14, 18 No carriers were found among 397 members of families with no known affected relative. The results confirm the extremely heterogeneous distribution of gene variants in such populations. 19 In theory, when the prevalence of carriers is 5 percent in the general population and 31 percent in families with an affected member, a person with an affected relative would have an approximately 1.6 percent chance of entering a marriage at risk for producing affected children (31 percent of 5 percent). The index families included 214 couples, 126 of whom were tested. Seventeen couples were found to be at risk -13 percent of those tested, or at least 8 percent of all couples. Thus, in these families, about 10 percent of couples are probably at risk, and carriers have a 20 to 30 percent chance of entering a marriage at risk for producing affected children.
Of the 17 couples found to be at risk, 11 were closely consanguineous and 6 were related only through the biradri. This finding suggests that variant genes are often trapped not only within extended families, but also in the larger biradri groupings from which many partners are drawn. The proposal that consanguineous marriage should be discouraged in such communities on genetic grounds is ethically unacceptable 2 ; it is also unrealistic, because more than 90 percent of marriag-The New Eng land Jour nal of Medicine *Since no carriers were identified in the control families, we did not calculate the numbers of married and unmarried family members tested. es occur within the biradri and logically would have to be discouraged. Such a wholesale attack on social structure has no chance of success. Our study shows that a real option for providing genetic counseling in a way that is compatible with the social mores and kinship structure of the Pakistani population involves accurate testing to identify carriers and the provision of precise information on the presence of risk.
T ABLE 2. AFFECTED CHILDREN, CARRIERS, MARRIAGES
The effectiveness of studies of families is compared with that of population screening in Table 3 . Family studies provide a highly effective approach to risk detection in Pakistani society. Population screening is less powerful, but follow-up of carriers can identify increased risk before the birth of any affected child (as it did in the case of Family 8). Therefore, the ideal policy is to provide both family studies and premarital or antenatal screening for the relatives of affected children. This combined approach is a long-term strategy, and its effects are likely to increase with timeassuming that ways are found to help families to retain genetic information (which they tend to forget) and to ensure that each new generation is offered testing to identify carriers.
It is worth determining whether persons are at risk only if they wish to know about it and can use the information provided. The main choices open to those who are at risk are avoiding marriage to another carrier or using prenatal diagnosis. Information on carrier status has little effect on the choice of partners in Mediterranean countries. 10, 20 This generalization may or may not be applicable in communities in which many marriages are arranged, but there is very little systematic understanding of how such marriages come about -for example, who suggests them, at what age possible partners are identified, and what part is played by the preferences of the young persons themselves. Our observations suggest that close relatives accept marriage with a carrier more easily than unrelated persons do. In the latter situation, it may be particularly difficult for the parents of a woman who is a carrier to ask that a potential partner be tested; most family members said that their preferred solution in such a situation is to postpone testing until after marriage and then to use prenatal diagnosis if required.
As has been reported in Western studies, 10,21 most couples in our study who were found to be at risk and who had two or more healthy children avoided further pregnancy; many with one healthy child or none requested prenatal diagnosis; and some avoided any intervention in pregnancy for religious reasons. Our observations to date do not permit any firm conclusions other than that many families use information about risk to avoid problems as far as possible.
Our study confirms that in communities in which consanguineous marriage is common, an approach targeting the extended family is useful because it produces a high yield of information on carriers and couples at risk; family members often understand the condition because they have had contact with an affected child; and usually only one gene variant is present in a given family, simplifying and reducing the cost of DNA-based diagnosis. The approach also overcomes problems such as a weak health care infrastructure (because the family study can be undertaken at the center where the index case of the disorder is diagnosed and treated) and a low level of literacy (because information is communicated directly between families with affected children who are attending the center). It is also an equitable approach that can be built into services as they are developed and so reach the gradually growing proportion of the population with access to services. In developed countries where labor costs are high, the fact that extended family studies are laborintensive might be a detraction. Since labor costs are proportionate to a country's resources, they are proportionately low in developing countries, where the primary difficulty is the high cost of reagents that must be purchased abroad. Our study has more than local relevance; the conclusions are applicable for all recessive disorders in populations where consanguineous marriage is common. It is estimated that about 10 percent of congenital and genetic disorders worldwide are associated with customary consanguineous marriage; in most of the Middle East, the proportion is 30 percent, and in Pakistan, it is 40 percent. 1, 2 The growing number of facilities providing DNA-based diagnostic services for hemoglobin disorders provides a basis for far broader clinical molecular-genetics services capable of applying many new techniques for the accurate diagnosis of these disorders. It will take a long time to implement the approach in developing countries; it should be possible to deploy it more rapidly in the sizable communities favoring consanguineous marriage that reside, for example, in the United Kingdom and Scandinavia, 22, 23 where resources for genetic testing are comparatively abundant.
